New drug E7090 tested in patients with advanced solid tumors
NCT ID NCT02275910
First seen Jan 10, 2026 · Last updated Jun 18, 2026 · Updated 24 times
Summary
This early-phase study tested an experimental drug called E7090 in 40 adults with advanced solid tumors that had not responded to standard treatments. The goal was to find the safest dose and check for early signs of effectiveness, especially in patients whose tumors have certain genetic changes in the FGF/FGFR pathway. The study focused on safety and tolerability, not on curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eisai Trial Site #1
Nagoya, Aichi-ken, Japan
-
Eisai Trial Site #1
Kashiwa, Chiba, Japan
-
Eisai Trial Site #1
Matsuyama, Ehime, Japan
-
Eisai Trial Site #1
Sapporo, Hokkaido, Japan
-
Eisai Trial Site #1
Amagasaki, Hyōgo, Japan
-
Eisai Trial Site #1
Tsukuba, Ibaraki, Japan
-
Eisai Trial Site #1
Kawasaki, Kanagawa, Japan
-
Eisai Trial Site #1
Yokohama, Kanagawa, Japan
-
Eisai Trial Site #1
Chuo-ku, Niigata, Japan
-
Eisai Trial Site #1
Kitaadachi, Saitama, Japan
-
Eisai Trial Site #1
Chuo-Ku, Tokyo, Japan
-
Eisai Trial Site #1
Koto-ku, Tokyo, Japan
-
Eisai Trial Site #1
Chiba, Japan
-
Eisai Trial Site #1
Fukuoka, Japan
-
Eisai Trial Site #1
Kyoto, Japan
-
Eisai Trial Site #1
Osaka, Japan
-
Eisai Trial Site #2
Osaka, Japan
-
Eisai Trial Site #3
Osaka, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.